1Houek KA, Leung DW, Rowland AM, et al. Dual regulation of vascular growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem, 1992, 267(36) :26031 - 26037.
2Terman BI, Carrion ME, Kovosc E, et al. Indentification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene, 1993, 6: 1677- 1683.
3Robinson CJ, Stringer SE.The splice variants of vascular endothelial growth factor(VEGF) and their receptors.J Cell Sci, 2001,114:853- 865.
4Lu J, Kasama T, Kobayashi K, et al. Vascular endothelial growth factor and regulation of murine collagen-induced arthritis. J Immunol, 2000, 164: 5922- 5927.
5Yamada T, Sawatsubashi M, Yakushiji H, et al. Localization of vascular endothelial growth factor in synovial membrance mast cell: examination with“multi-labelling subtraction imrnunosraining”. Virchows Arch, 1998, 433 : 567 - 570.
6Pfander D, Kortje D, Zirnrnermann R, et al. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis, 2001, 60: 1070- 1073.
7Levy NS, Goldberg MA, Levy AP. Sequencing of the human vascular endothelial growth factor(VEGF) 3' untranslated region(UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochem Biophys Acta, 1997, 1352: 167-173.
8Bottomley MJ, Webb N J, Waston CJ, et al. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumor necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol, 1999, 117: 171-176.
9Hitchon C, Wong K, Reed J, et al. Hypoxia-induced production of stromal cell derived factor(CXCL12)and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum, 2002, 46(10) : 2587 - 2597.
10Tsumuki H, Hasunuma T, Kobata T, et al. Basic FGF-induced activation of telomerase in rheumatoid synoviocytes. Rheumatol Int, 2000, 19:123- 128.
